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Endothelial colony forming cells (ECFCs) are the only endothelial progenitor cells 
(EPCs) subtype belonging to the endothelial phenotype and capable of forming neoves-
sels in vivo. We have recently shown that the intracellular Ca2+ machinery plays a key 
role in ECFC activation and is remodeled in ECFCs isolated from patients suffering from 
renal cellular carcinoma (RCC-ECFCs). More specifically, ECFCs upregulate the store-oper-
ated Ca2+ entry (SOCE) machinery, while they seemingly show a reduction in the Ca2+ 
concentration within the endoplasmic reticulum ([Ca2+]ER). Metastatic RCC patients are 
commonly treated with an anti-vascular endothelial growth factor (VEGF) therapy, but 
they show either intrinsic or adaptive refractoriness, which ultimately leads to their death. 
Herein, we assessed whether and how the rearrangement of the Ca2+ machinery impacts 
on the pro-angiogenic Ca2+ response to VEGF, which stimulates normal ECFCs (N-ECF-
Cs) through an oscillatory Ca2+ response. We found that VEGF stimulates the nuclear 
translocation of p65/RelA, a major component of the Ca2+-dependent transcription fac-
tor NF-kB, in N-ECFCs. This process is blocked by the pharmacological abrogation of 
VEGF-induced Ca2+ oscillations. We further showed that NF-kB controls VEGF-induced 
protein expression of E-selectin, VCAM-1 and MMP9. Likewise, VEGF-induced expression 
was also inhibited by the pharmacological suppression of the accompanying Ca2+ spikes. 
Thus, VEGF induces a Ca2+-dependent, NF-kB-mediated protein expression in N-ECFCs. 
VEGF did not trigger protein expression in RCC-ECFCs despite the fact that VEGFR-2 was 
normally expressed and auto-phosphorylated. Our subsequent studies employed the tar-
geted recombinant Ca2+-sensitive photoprotein aequorin to confirm that [Ca2+]ER is lower 
in RCC-ECFCs; surprisingly, electron microscopy analysis revealed that the endoplasmic 
reticulum cisternae are enlarged rather than shrinked in these cells. These results show 
for the first time that VEGF fails to stimulate tumor-derived ECFCs: these findings could 
therefore help to understand the relative failure of anti-VEGF treatment in RCC patients.
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